- Published on
Infectious Disease and Microbiology – Flavobacterium Species
Overview
Flavobacterium species are aerobic Gram-negative bacilli historically associated with a variety of opportunistic and healthcare-associated infections. Important manifestations described in older literature include neonatal meningitis and bacteremia, prosthetic-valve endocarditis, contaminated-solution-associated bacteremia, and wound infection.
The taxonomy of this group has changed substantially, so several organisms formerly classified as Flavobacterium now belong to other genera.
Important Species
Historically recognized species include:
• Flavobacterium indologenes
• Flavobacterium meningosepticum
• Flavobacterium odoratum
• Other Flavobacterium species
Several of these names are now considered older taxonomic designations.
Important Taxonomic Changes
A major point when reading older infectious-disease literature is that:
Flavobacterium meningosepticum → now Elizabethkingia meningoseptica
Flavobacterium indologenes → now Chryseobacterium indologenes
Thus, older reports of Flavobacterium infection may actually describe organisms currently classified as Elizabethkingia or Chryseobacterium.
Microbiologic Characteristics
Historically classified Flavobacterium organisms are:
• Aerobic
• Gram-negative bacilli
• Generally environmental organisms
• Capable of causing opportunistic and healthcare-associated infection
The source correctly notes that the taxonomy was unsettled; subsequent reclassification has substantially reorganized these organisms.
Clinical Infections
Reported infections include:
• Meningitis
• Bacteremia
• Prosthetic-valve endocarditis
• Healthcare-associated outbreaks
• Wound infection
Clinical manifestations vary considerably according to the species and host.
Neonatal Meningitis
The organism historically called F. meningosepticum is particularly associated with:
Meningitis in newborns
Neonatal infection can be severe and may occur in healthcare settings.
This organism is now known as Elizabethkingia meningoseptica.
Neonatal Bacteremia
In addition to meningitis, E. meningoseptica can cause neonatal bacteremia and sepsis.
Premature and medically complex newborns may be particularly vulnerable to invasive infection.
Endocarditis
Organisms historically included in the Flavobacterium group have occasionally caused infective endocarditis.
The source particularly emphasizes infection involving:
Prosthetic heart valves
This represents a rare but serious invasive manifestation.
Nosocomial Bacteremia
Healthcare-associated outbreaks of bacteremia have been reported.
A particularly important epidemiologic association is:
Contaminated solutions
Such outbreaks demonstrate the ability of these environmental Gram-negative organisms to contaminate healthcare materials and cause invasive disease in susceptible patients.
Wound Infection
Flavobacterium-group organisms have also been associated with wound infections.
Their clinical significance should be interpreted according to the specimen source, evidence of tissue inflammation, and the patient’s underlying condition.
Diagnosis
Diagnosis is established by:
Culture of the pathogen
Accurate identification is particularly important because:
• Taxonomy has changed
• These are uncommon organisms
• Antimicrobial susceptibility may be unusual
• Resistance to multiple conventional Gram-negative antibiotics can occur
Antimicrobial Susceptibility
A major clinical feature of organisms such as Elizabethkingia meningoseptica is their unusual antimicrobial susceptibility pattern.
They may be resistant to several antibiotics ordinarily used against Gram-negative bacteria.
Therefore, treatment should be based on:
Accurate species identification + antimicrobial susceptibility testing
Treatment
The source lists:
Ciprofloxacin
as a treatment option.
Because susceptibility can vary substantially, modern management of serious infection should be guided by isolate-specific susceptibility testing rather than assuming that a particular agent will always be effective.
Historical Vancomycin Treatment
The source describes reports of successful treatment of neonatal meningitis with:
Vancomycin
This was historically notable because vancomycin ordinarily has little or no useful activity against Gram-negative bacteria.
However, the statement that Flavobacterium is uniquely susceptible to vancomycin reflects older literature and should not be treated as a modern general treatment rule.
Why Vancomycin Is Unusual
Normally:
Gram-negative outer membrane
→ prevents effective penetration of vancomycin
→ intrinsic lack of useful vancomycin activity
Therefore, historical reports involving F. meningosepticum were microbiologically unusual and became a memorable feature of older teaching material.
High-Yield Clinical Pattern
Newborn
- ●
Meningitis or bacteremia
- ●
Unusual aerobic Gram-negative bacillus
- ●
Healthcare-associated setting
→ Think Elizabethkingia meningoseptica
(formerly Flavobacterium meningosepticum)
Nosocomial Pattern
Cluster of bloodstream infections
- ●
Hospitalized patients
- ●
Possible contaminated medical solution
→ Consider an environmental Gram-negative organism historically classified among Flavobacterium
Exam Essentials
Historical genus: Flavobacterium
Type: Aerobic Gram-negative bacilli
Important old species: F. meningosepticum
Current name: Elizabethkingia meningoseptica
Old F. indologenes: Now Chryseobacterium indologenes
Classic severe infection: Neonatal meningitis and bacteremia
Other infection: Prosthetic-valve endocarditis
Nosocomial outbreaks: May involve contaminated solutions
Additional infection: Wound infection
Diagnosis: Culture
Important issue: Unusual and potentially multidrug-resistant susceptibility patterns
Treatment in source: Ciprofloxacin
Historical treatment observation: Vancomycin was reported for neonatal meningitis
Modern treatment principle: Susceptibility-guided antimicrobial therapy
Key clinical pearl: The most important association in older literature is Flavobacterium meningosepticum + neonatal meningitis/bacteremia. Remember that this organism has been reclassified as Elizabethkingia meningoseptica and has an unusual antimicrobial resistance profile, making accurate identification and susceptibility-guided therapy particularly important.